Skip to search formSkip to main contentSkip to account menu

GRN1005

National Institutes of Health

Related topics

Related topics

2 relations
ANG1005

Broader (1)

paclitaxel-Angiopep-2 conjugate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Abstract P4-01-09: 18F-FLT-PET/CT for the prediction of response to ANG-1005 therapy in patients with brain metastases from breast cancer
Background: ANG1005 (formerly called GRN1005) is a peptide-drug conjugate being developed for targeted treatment of brain… 
Review
2012
Review
2012
Abstract P3-12-04: A phase 2, multi-center, open label study evaluating the efficacy and safety of GRN1005 alone or in combination with trastuzumab in patients with brain metastases from breast…
Rationale: Treatment of brain metastasis (BM) remains an unmet medical need due to the inability of most anti-cancer agents to… 
2011
2011
Abstract B49: GRN1005 phase I studies: Final results.
Background: Treatment of brain tumors is an unmet medical need due to the inability of most anti-cancer agents to effectively… 
2011
2011
Retinoid-regulated FGF 8 f secretion by osteoblasts bypasses retinoid stimuli to mediate granulocytic differentiation of myeloid leukemia cells
1 Retinoid-regulated FGF8f secretion by osteoblasts bypasses retinoid stimuli to mediate granulocytic differentiation of myeloid… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)